Popular Pre-Market Trades in U.S. Stocks
SciSparc is down 10.60% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 29, SciSparc's subsidiary NeuroThera Labs received conditional approval to acquire a 54% stake in CliniQuantum, causing the stock price to surge over 164% during the day. This strategic move is seen as enhancing market position, with trading volume significantly above average, reflecting increased investor interest. Source: Zhitong Finance
</li>
<li>
On May 29, SciSparc's stock price rose 157.05% to $11.31. This increase is related to the company's equity trading, with the market holding an optimistic outlook on its future development. Source: Benzinga
</li>
<li>
On May 29, SciSparc's stock price activity indicated that the price increase was related to the final determination of a tax ruling in Israel, with all shares entering a custody agreement. Source: Benzinga AI Investment Boom, Market Volatility Intensifies
</li>
</ol>
Nebius is up 6.90% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 29, the fund of former OpenAI employee Leopold Aschenbrenner disclosed a 5% stake in Nebius, valued at $2.6 billion, becoming the largest shareholder and driving the stock price up. Source: MoneyDJ
</li>
<li>
On May 28, Nebius signed a fuel cell capacity agreement with Bloom Energy to meet the power needs of data centers, further boosting market confidence. Source: Benzinga
</li>
<li>
On May 29, Nebius reported a 684% year-over-year increase in first-quarter revenue, exceeding market expectations, leading to a significant rise in stock price. Source: MoneyDJ AI Strong Demand for Infrastructure, Broad Industry Prospects.
</li>
</ol>
Top Gainers in Pre-Market U.S. Stocks
Genenta Science S.P.A. is up 137.86% in pre-market trading. Based on recent key news:
<ol>
<li>On May 29, Genenta Science S.p.A. released important information through the EDGAR system of the U.S. Securities and Exchange Commission. The release of this information sparked positive expectations for the company's future development, leading to a significant rise in stock price. The biotechnology sector has been highly volatile recently.</li>
</ol>
Volato is up 134.29% in pre-market trading, with no significant news recently. Trading is active, and capital flow is evident. Considering sector and industry trends, this stock shows notable volatility, and specific reasons need further observation.
Hitek Global Inc. is up 115.07% in pre-market trading, with no significant news recently. Trading is active, and capital flow is evident. Considering sector and industry trends, this stock shows notable volatility, and specific reasons need further observation

SPRC

NBIS

SciSparc pre-market down 10.60%; Nebius pre-market up 6.90%; Genenta Science S.P.A. pre-market up 137.86%; Volato pre-market up 134.29%; Hitek Global Inc. pre-market up 115.07%

Price Alert

SciSparc

Pre-market hot trades in US stocks: SciSparc pre-market down 10.60%; Nebius pre-market up 6.90%